Khondrion Advances Innovative Therapy for Mitochondrial Disease with €5 Million Support Khondrion receives €5 million from the Dutch government plus private investments to fund Phase 3 clinical trials for mitochondrial disease treatments.

Khondrion Advances Innovative Therapy for Mitochondrial Disease with €5 Million Support #Netherlands #Nijmegen #Khondrion #Mitochondrial_Disease #Sonlicromanol